SCHEMBL21875099

SCHEMBL21875099

COc1ccc(S(=O)(=O)n2ccc(C(=O)NCc3ccn(C)n3)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 5/20 0.59
▸ HPGDS O60760 1/20 0.55
▸ ALDH1A1 P00352 5/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ NAMPT P43490 1/20 0.42
▸ MAPT P10636 3/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21875135 0.88 KLKB1 (0.48) KLKB1HPGDSALDH1A1KMT2ANAMPT
SCHEMBL21875139 0.87 NAMPT (0.48) KLKB1HPGDSALDH1A1NAMPT
SCHEMBL21875090 0.87 PKM (0.54) KLKB1HPGDSALDH1A1KDM4EHPGD
SCHEMBL21875119 0.84 HPGDS (0.55) KLKB1HPGDSALDH1A1CYP1A2CYP3A4
SCHEMBL21875128 0.82 KLKB1 (0.58) KLKB1ALDH1A1HSD17B10KMT2AMEN1
SCHEMBL21875107 0.82 KLKB1 (0.58) KLKB1HPGDSALDH1A1CYP1A2CYP3A4
SCHEMBL21875164 0.82 KLKB1 (0.60) KLKB1ALDH1A1CYP1A2CYP3A4TP53
SCHEMBL21875152 0.82 KLKB1 (0.60) KLKB1ALDH1A1CYP1A2CYP3A4TP53
SCHEMBL24620546 0.81 HPGDS (0.50) KLKB1HPGDSALDH1A1CYP1A2CYP3A4
SCHEMBL21875103 0.80 KLKB1 (0.49) KLKB1HPGDSALDH1A1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN claimed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US claimed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS KCNA3, KCNN3, KCNK3 KLKB1 784/4885HPGDS 4079/4885ALDH1A1 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback